The effect of antiresorptives on bone quality

Clinical Orthopaedics and Related Research

Volumn 469, Issue 8, 2011, Pages 2207-2214

  Recker, Robert R ^a   Armas, Laura ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS AFFECTING METABOLISM; ANTIRESORPTIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; DENOSUMAB; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; UNCLASSIFIED DRUG;

BONE CHARACTERISTICS AND FUNCTIONS; BONE DEFECT; BONE DENSITY; BONE EXAMINATION; BONE FRAGILITY; BONE MASS; BONE QUALITY; BONE REMODELING; BONE STRENGTH; BONE STRUCTURE; CONFERENCE PAPER; DRUG EFFICACY; DRUG MECHANISM; FRACTURE; HUMAN; OSTEOGENESIS IMPERFECTA; OSTEOPOROSIS; PAGET BONE DISEASE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; REPEATED DRUG DOSE; RISK REDUCTION; SINGLE DRUG DOSE;

EID: 79960945083     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-011-1909-8     Document Type: Conference Paper

References (69)

1. O Akkus CM Rimnac 2001 Cortical bone tissue resists fatigue fracture by deceleration and arrest of microcrack growth J Biomech. 34 757 764 11470113 10.1016/S0021-9290(01)00025-2 1:STN:280:DC%2BD3MvhslGmtg%3D%3D (Pubitemid 32674354)
2. Allen MR, Burr DB. Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: what we think we know and what we know that we don't know. Bone. 2010 October 16 [Epub ahead of print].
3. MR Allen E Gineyts DJ Leeming DB Burr PD Delmas 2008 Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra Osteoporos Int. 19 329 337 18094911 10.1007/s00198-007-0533-7 1:CAS:528:DC%2BD1cXhtlOqsLk%3D
4. MR Allen HA Hogan WA Hobbs AS Koivuniemi MC Koivuniemi DB Burr 2007 Raloxifene enhances material-level mechanical properties of femoral cortical and trabecular bone Endocrinology. 148 3908 3913 17478550 10.1210/en.2007-0275 1:CAS:528:DC%2BD2sXot1OitL4%3D (Pubitemid 47105862)
5. MR Allen K Iwata R Phipps DB Burr 2006 Alterations in canine vertebral turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate Bone. 39 872 879 16765660 10.1016/j.bone.2006.04.028 1:CAS:528: DC%2BD28XpsVOhurY%3D (Pubitemid 44311727)
6. Baron R, Vignery A, Neff L, Silvergate A, Santa Maria A. Processing of undecalcified bone specimens for bone histomorphometry. In: Recker RR, ed. Bone Histomorphometry: Techniques and Interpretation. Boca Raton, FL: CRC Press; 1983:13-36.
7. E Barrett-Connor L Mosca P Collins MJ Geiger D Grady M Kornitzer MA McNabb NK Wenger Raloxifene Use for the Heart (RUTH) Trial Investigators 2006 Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women N Engl J Med. 355 125 137 16837676 10.1056/NEJMoa062462 1:CAS:528:DC%2BD28Xmsl2ktrs%3D (Pubitemid 44050394)
8. V Bentolila TM Boyce DP Fyhrie R Drumb TM Skerry MB Schaffler 1998 Intracortical remodeling in adult rat long bones after fatigue loading Bone. 23 275 281 9737350 10.1016/S8756-3282(98)00104-5 1:STN:280:DyaK1cvgslelug%3D%3D (Pubitemid 28434672)
9. DM Black MP Kelly HK Genant L Palermo R Eastell C Bucci-Rechtweg J Cauley PC Leung S Boonen A Santora A de Papp DC Bauer Fracture Intervention Trial and HORIZON Pivotal Fracture Trial Steering Committees 2010 Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur N Engl J Med. 362 1761 1771 20335571 10.1056/NEJMoa1001086 1:CAS:528:DC%2BC3cXmtVSrsr4%3D
10. G Boivin PJ Meunier 2002 The degree of mineralization of bone tissue measured by computerized quantitative contact microradiography Calcif Tissue Int. 70 503 511 12019458 10.1007/s00223-001-2048-0 1:CAS:528: DC%2BD38XlvV2ktLo%3D (Pubitemid 36929589)
11. GY Boivin PM Chavassieux AC Santora J Yates PJ Meunier 2000 Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women Bone. 27 687 694 11062357 10.1016/S8756-3282(00) 00376-8 1:CAS:528:DC%2BD3cXosFygtL8%3D
12. HG Bone SL Greenspan C McKeever N Bell M Davidson RW Downs R Emkey PJ Meunier SS Miller AL Mulloy RR Recker SR Weiss N Heyden T Musliner S Suryawanshi AJ Yates A Lombardi 2000 Alendronate and estrogen effects in postmenopausal women with low bone mineral density J Endocrinol Metab. 85 720 726 10.1210/jc.85.2.720 1:CAS:528:DC%2BD3cXhtlyhu7g%3D (Pubitemid 32273660)
13. AL Boskey E DiCarlo E Paschalis P West R Mendelsohn 2006 Comparison of mineral quality and quantity in iliac crest biopsies from high- and low-turnover osteoporosis: an FT-IR microspectroscopic investigation Osteoporos Int. 16 2031 2038 10.1007/s00198-005-1992-3 (Pubitemid 41790924)
14. TC Brennan R Rizzoli P Ammann 2009 Selective modification of bone quality by PTH, pamidronate, or raloxifene J Bone Miner Res. 24 800 808 19063681 10.1359/jbmr.081227 1:CAS:528:DC%2BD1MXlvVWhtb8%3D
15. JP Brown RL Prince C Deal RR Recker DP Kiel LH de Gregorio P Hadji LC Hofbauer JM Alvaro-Gracia H Wang M Austin RB Wagman R Newmark C Libanati J San Martin HG Bone 2009 Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial J Bone Miner Res. 24 153 161 18767928 10.1359/jbmr.0809010 1:CAS:528:DC%2BD1MXht1yrtbc%3D
16. D Burr 2003 Microdamage and bone strength Osteoporos Int. 14 S67 S72 14504709 10.1007/s00198-003-1476-2
17. DB Burr 2002 Targeted and nontargeted remodeling Bone. 30 2 4 11792556 10.1016/S8756-3282(01)00619-6 1:STN:280:DC%2BD38%2FmvVWmsg%3D%3D (Pubitemid 34044293)
18. DB Burr MR Allen 2008 Low bone turnover and microdamage: how and where to assess it? J Bone Miner Res. 23 1150 1151 18348687 10.1359/jbmr.080307 (Pubitemid 351915737)
19. DB Burr MR Forwood DP Fyhrie RB Martin MB Schaffler CH Turner 1997 Bone microdamage and skeletal fragility in osteoporotic and stress fractures J Bone Miner Res. 12 6 15 9240720 10.1359/jbmr.1997.12.1.6 1:STN:280: DyaK2szot1OgtQ%3D%3D (Pubitemid 27053606)
20. DB Burr MB Schaffler RG Frederickson 1988 Composition of the cement line and its possible mechanical role as a local interface in human compact bone J Biomech. 21 939 944 3253280 10.1016/0021-9290(88)90132-7 1:STN:280: DyaL1MzgvVOiuw%3D%3D (Pubitemid 19008970)
21. L Cardoso BC Herman O Verborgt D Laudier RJ Majeska MB Schaffler 2009 Osteocyte apoptosis controls activation of intracortical resorption in response to bone fatigue J Bone Miner Res. 24 597 605 19049324 10.1359/jbmr.081210 1:CAS:528:DC%2BD1MXksF2ksro%3D
22. A Cohen S Liu EM Stein DJ McMahon HF Rogers J LeMaster RR Recker JM Lappe XE Guo E Shane 2009 Bone microarchitecture and stiffness in premenopausal women with idiopathic osteoporosis J Clin Endocrinol Metab. 94 4351 4360 19837923 10.1210/jc.2009-0996 1:CAS:528:DC%2BD1MXhsVejtLfM
23. NJ Crane V Popescu MD Morris P Steenhuis MA Ignelzi Jr 2006 Raman spectroscopic evidence for octacalcium phosphate and other transient mineral species deposited during intramembranous mineralization Bone. 39 434 442 16627026 10.1016/j.bone.2006.02.059 1:CAS:528:DC%2BD28XotFyksLs%3D (Pubitemid 44149267)
24. SR Cummings DB Karpf F Harris HK Genant K Ensrud AZ LaCroix DM Black 2002 Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs Am J Med. 112 281 289 11893367 10.1016/S0002-9343(01)01124-X 1:CAS:528:DC%2BD38XhvVWkurk%3D (Pubitemid 34219441)
25. SR Cummings JL Kelsey MC Nevitt KJ O'Dowd 1985 Epidemiology of osteoporosis and osteoporotic fractures Epidemiol Rev. 7 178 208 3902494 1:STN:280:DyaL28%2FjtVGntA%3D%3D (Pubitemid 15236006)
26. SR Cummings J San Martin MR McClung ES Siris R Eastell IR Reid P Delmas HB Zoog M Austin A Wang S Kutilek S Adami J Zanchetta C Libanati S Siddhanti C Christiansen FREEDOM trial 2009 Denosumab for prevention of fractures in postmenopausal women with osteoporosis N Engl J Med. 361 756 765 19671655 10.1056/NEJMoa0809493 1:CAS:528:DC%2BD1MXhtVWls7nF
27. PD Delmas KE Ensrud JD Adachi KD Harper S Sarkar C Gennari JY Reginster HA Pols RR Recker ST Harris W Wu HK Genant DM Black R Eastell 2002 Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial J Clin Endocrinol Metab. 87 3609 3617 12161484 10.1210/jc.87.8.3609 1:CAS:528:DC%2BD38XmtF2gsLg%3D (Pubitemid 34879503)
28. Z Fan JG Swadener JY Rho ME Roy GM Pharr 2002 Anisotropic properties of human tibial cortical bone as measured by nano-indentation J Orthop Res. 20 806 810 12168671 10.1016/S0736-0266(01)00186-3 1:STN:280:DC%2BD38vhsV2gtg%3D%3D (Pubitemid 34823002)
29. A Feher A Koivunemi M Koivunemi RK Fuchs DB Burr RJ Phipps S Reinwald MR Allen 2010 Bisphosphonates do not inhibit periosteal bone formation in estrogen deficient animals and allow enhanced bone modeling in response to mechanical loading Bone. 46 203 207 19857619 10.1016/j.bone.2009.10.023 1:CAS:528:DC%2BD1MXhsFynsrrL
30. Frost HM. Intermediary Organization of the Skeleton. Boca Raton, FL: CRC Press; 1986.
31. M Gnant B Mlineritsch W Schippinger G Luschin-Ebengreuth S Postlberger C Menzel R Jakesz M Seifert M Hubalek V Bjelic-Radisic H Samonigg C Tausch H Eidtmann G Steger W Kwasny P Dubsky M Fridrik F Fitzal M Stierer E Rucklinger 2009 Greil R; ABCSG-12 Trial Investigators. Endocrine therapy plus zoledronic acid in premenopausal breast cancer N Engl J Med. 360 679 691 19213681 10.1056/NEJMoa0806285 1:CAS:528:DC%2BD1MXhvVyisbk%3D
32. Y Gong M Vikkula L Boon J Liu P Beighton R Ramesar L Peltonen H Somer T Hirose B Dallapiccola A de Paepe W Swoboda B Zabel A Superti-Furga B Steinmann HG Brunner A Jans RG Boles W Adkins MJ van den Boogaard BR Olsen ML Warman 1996 Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13 Am J Hum Genet. 59 146 151 8659519 1:CAS:528:DyaK28XksFSitr4%3D (Pubitemid 26189740)
33. SL Greenspan RD Emkey HG Bone 3rd SR Weiss NH Bell RW Downs Jr C McKeever SS Miller M Davidson MA Bolognese AL Mulloy N Heyden M Wu A Kaur A Lombardi 2002 Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis Ann Intern Med. 137 875 883 12458987 1:CAS:528:DC%2BD38XpsFWku78%3D (Pubitemid 35416623)
34. RP Heaney 2003 How does bone support calcium homeostasis? Bone. 33 264 268 13678766 10.1016/S8756-3282(03)00218-7 1:CAS:528:DC%2BD3sXnt1GlsL4%3D (Pubitemid 37103242)
35. RP Heaney RR Recker PD Saville 1978 Menopausal changes in bone remodeling J Lab Clin Med. 92 964 970 739174 1:STN:280:DyaE1M7htVOqtA%3D%3D (Pubitemid 9090267)
36. RP Heaney AJ Yates AC Santora II 1997 Bisphosphonate effects and the bone remodeling transient J Bone Miner Res. 12 1143 1151 9258743 10.1359/jbmr.1997.12.8.1143 1:STN:280:DyaK2svgtlektg%3D%3D (Pubitemid 27334959)
37. TJ Heino K Kurata H Higaki HK Vaananen 2009 Evidence for the role of osteocytes in the initiation of targeted remodeling Technol Health Care. 17 49 56 19478405
38. BC Herman L Cardoso RJ Majeska KJ Jepsen MB Schaffler 2010 Activation of bone remodeling after fatigue: differential response to linear microcracks and diffuse damage Bone. 47 766 772 20633708 10.1016/j.bone.2010.07.006 1:STN:280:DC%2BC3cfgvFCjuw%3D%3D
39. T Hirano CH Turner MR Forwood CC Johnston DB Burr 2000 Does suppression of bone turnover impair mechanical properties by allowing microdamage accumulation? Bone. 27 13 20 10865204 10.1016/S8756-3282(00)00284-2 1:STN:280:DC%2BD3cvisVCgsA%3D%3D (Pubitemid 30365072)
40. ZF Jaworski M Liskova-Kiar HK Uhthoff 1980 Effect of long-term immobilisation on the pattern of bone loss in older dogs J Bone Joint Surg Br. 62 104 110 6985912 (Pubitemid 10212871)
41. NM Keshawarz RR Recker 1984 Expansion of the medullary cavity at the expense of cortex in postmenopausal osteoporosis Metab Bone Dis Relat Res. 5 223 228 6493034 10.1016/0221-8747(84)90063-8 1:STN:280:DyaL2M%2FjsFOhsg%3D%3D (Pubitemid 14069655)
42. A Laib DC Newitt Y Lu S Majumdar 2002 New model-independent measures of trabecular bone structure applied to in vivo high-resolution MR images Osteoporos Int. 13 130 136 11905523 10.1007/s001980200004 1:STN:280: DC%2BD387ntlagtw%3D%3D (Pubitemid 34241033)
43. KC Lasseter AG Porras A Denker A Santhanagopal A Daifotis 2005 Pharmacokinetic considerations in determining the terminal elimination half-lives of bisphosphonates Clin Drug Invest. 25 107 114 10.2165/00044011- 200525020-00003 1:CAS:528:DC%2BD2MXis1WrsL4%3D (Pubitemid 40314651)
44. BA Lenart DG Lorich JM Lane 2008 Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate N Engl J Med. 358 1304 1306 18354114 10.1056/NEJMc0707493 1:CAS:528:DC%2BD1cXjvVarsb8%3D (Pubitemid 351439247)
45. UA Liberman SR Weiss J Broll HW Minne H Quan NH Bell J Rodriguez-Portales RW Downs Jr J Dequeker M Favus E Seeman RR Recker T Capizzi AC Santora 2nd A Lombardi RV Shah LJ Hirsch 1995 Karpf DB; Alendronate Phase III Osteoporosis Treatment Study Group. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis N Engl J Med. 333 1437 1443 7477143 10.1056/NEJM199511303332201 1:CAS:528:DyaK28XkslehtA%3D%3D
46. P Masarachia M Weinreb R Balena GA Rodan 1996 Comparison of the distribution of 3H-alendronate and 3H-etidronate in rat and mouse bones Bone. 19 281 290 8873969 10.1016/8756-3282(96)00182-2 1:CAS:528:DyaK28XlvFehtb0%3D (Pubitemid 26305769)
47. T Mashiba T Hirano CH Turner MR Forwood CC Johnston DB Burr 2000 Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib J Bone Miner Res. 15 613 620 10780852 10.1359/jbmr.2000.15.4.613 1:CAS:528:DC%2BD3cXisFWmtr4%3D (Pubitemid 30174014)
48. T Mashiba CH Turner T Hirano MR Forwood CC Johnston DB Burr 2001 Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles Bone. 28 524 531 11344052 10.1016/S8756-3282(01)00414-8 1:CAS:528:DC%2BD3MXjtlChsLk%3D (Pubitemid 32416465)
49. H Melhus U Riserus E Warensjo L Wernroth K Jensevik L Berglund B Vessby K Michaelsson 2008 A high activity index of stearoyl-CoA desaturase is associated with increased risk of fracture in men Osteoporos Int. 19 929 934 18066610 10.1007/s00198-007-0521-y 1:CAS:528:DC%2BD1cXmsFKnurc%3D
50. Melton LJ. Epidemiology of fractures. In; Riggs BL, Melton LJ, (eds) Osteoporosis: Etiology, Diagnosis and Management. 2nd ed. Philadelphia PA: Lippincott-Raven Press; 1995:225-247.
51. S Mori DB Burr 1993 Increased intracortical remodeling following fatigue damage Bone. 14 103 109 8334026 10.1016/8756-3282(93)90235-3 1:STN:280:DyaK3szis1Cmtw%3D%3D (Pubitemid 23098956)
52. S Mori R Harruff W Ambrosius DB Burr 1997 Trabecular bone volume and microdamage accumulation in the femoral heads of women with and without femoral neck fractures Bone. 21 521 526 9430242 10.1016/S8756-3282(97)00200-7 1:STN:280:DyaK1c%2FptVWjtQ%3D%3D (Pubitemid 28029695)
53. LE Mulcahy D Taylor TC Lee GP Duffy 2011 RANKL and OPG activity is regulated by injury size in networks of osteocyte-like cells Bone. 48 182 188 20854946 10.1016/j.bone.2010.09.014 1:CAS:528:DC%2BC3MXmvF2gsw%3D%3D
54. CV Odvina JE Zerwekh DS Rao N Maalouf FA Gottschalk CY Pak 2005 Severely suppressed bone turnover: a potential complication of alendronate therapy J Clin Endocrinol Metab. 90 1294 1301 15598694 10.1210/jc.2004-0952 1:CAS:528:DC%2BD2MXisVOhsr0%3D (Pubitemid 40463979)
55. SE Papapoulos M Frolich 1996 Prediction of the outcome of treatment of Paget's disease of bone with bisphosphonates from short-term changes in the rate of bone resorption J Clin Endocrinol Metab. 81 3993 3997 8923849 10.1210/jc.81.11.3993 1:CAS:528:DyaK28XntVCrs7g%3D (Pubitemid 26380407)
56. F Rauch H Plotkin R Travers L Zeitlin FH Glorieux 2003 Osteogenesis imperfecta types I, III and IV: effect of pamidronate therapy on bone and mineral metabolism J Clin Endocrinol Metab. 88 986 992 12629073 10.1210/jc.2002-021371 1:CAS:528:DC%2BD3sXit1egtbw%3D (Pubitemid 36337744)
57. R Recker J Lappe KM Davies R Heaney 2004 Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients J Bone Miner Res. 19 1628 1633 15355557 10.1359/JBMR.040710 (Pubitemid 41094325)
58. RR Recker SP Bare SY Smith A Varela MA Miller SA Morris J Fox 2009 Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84 Bone. 44 113 119 18983947 10.1016/j.bone.2008.09.019 1:CAS:528:DC%2BD1cXhsFahtLjJ
59. CT Rubin LE Lanyon 1984 Dynamic strain similarities in vertebrates: an alternative to allometric limb bone scaling J Theor Biol. 107 321 327 6717041 10.1016/S0022-5193(84)80031-4 1:STN:280:DyaL2c7ovF2itQ%3D%3D (Pubitemid 14108682)
60. RG Russell NB Watts FH Ebetino MJ Rogers 2008 Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy Osteoporos Int. 19 733 759 18214569 10.1007/s00198-007-0540-8 1:CAS:528:DC%2BD1cXltFyjurw%3D
61. M Saito S Mori T Mashiba S Komatsubara K Marumo 2008 Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs Osteoporos Int. 19 1343 1354 18373056 10.1007/s00198-008-0585-3 1:CAS:528:DC%2BD1cXps1Srsbg%3D
62. PD Saville RP Heaney RR Recker 1976 Radiogrammetry at four bone sites in normal middle-aged women Clin Orthop Relat Res. 114 307 315 1261127
63. MB Schaffler K Choi C Milgrom 1995 Aging and matrix microdamage accumulation in human compact bone Bone. 17 521 525 8835305 10.1016/8756- 3282(95)00370-3 1:STN:280:DyaK28vjt1aguw%3D%3D (Pubitemid 26017572)
64. F Selker DR Carter 1989 Scaling of long bone fracture strength with animal mass J Biomech. 22 1175 1183 2625417 10.1016/0021-9290(89)90219-4 1:STN:280:DyaK3c7ntFSjsA%3D%3D (Pubitemid 20097585)
65. JJ Stepan DB Burr I Pavo A Sipos D Michalska J Li A Fahrleitner-Pammer H Petto M Westmore D Michalsky M Sato H Dobnig 2007 Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis Bone. 41 378 385 17597017 10.1016/j.bone.2007.04.198 (Pubitemid 47199146)
66. SY Tang U Zeenath D Vashishth 2007 Effects on non-enzymatic glycation on cancellous bone fragility Bone. 40 1144 1151 17257914 10.1016/j.bone.2006.12.056 1:CAS:528:DC%2BD2sXjtVaktr4%3D (Pubitemid 46386561)
67. O Verborgt G Gibson MB Schaffler 2000 Loss of osteocyte integrity in association with microdamage and bone remodeling after fatigue in vivo J Bone Miner Res. 15 60 67 10646115 10.1359/jbmr.2000.15.1.60 1:STN:280: DC%2BD3c7htFGrtg%3D%3D (Pubitemid 30026933)
68. X Wang X Shen X Li CM Agrawal 2002 Age-related changes in the collagen network and toughness of bone Bone. 31 1 7 12110404 10.1016/S8756-3282(01)00697- 4 (Pubitemid 34754417)
69. YN Yeni DP Fyhrie 2002 Fatigue damage-fracture mechanics interaction in cortical bone Bone. 30 509 514 11882466 10.1016/S8756-3282(01)00696-2 1:STN:280:DC%2BD387kvF2rsA%3D%3D (Pubitemid 34204127)